This also suggests that TP53 mutation status may play a critical role in cellular processes previously shown to involve NOX4, such as EMT, cell migration, angiogenesis and other genetic and metabolic programs that promote cancer progression [15,16,20,37,38]. This evidence concerns the gene TP53 and cancer.